Alnylam Pharmaceuticals Reports First Quarter 2015 Financial Results and Highlights Recent Period Progress

Go back to Alnylam Pharmaceuticals Reports First Quarter 2015 Financial Results and Highlights Recent Period Progress

Alnylam Pharma (ALNY) Tops Q1 EPS by 4c

May 7, 2015 4:01 PM EDT

Alnylam Pharma (NASDAQ: ALNY) reported Q1 EPS of ($0.62), $0.04 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $18.51 million versus the consensus estimate of $15.4 million.

For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.

... More